Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Total revenue $ 539 $ 129
Costs of revenue 118 80
Gross profit 421 49
Operating expenses:    
Research and development 2,200 1,653
General and administrative 1,169 856
Sales and marketing 310 394
Grant expenses 299 26
Total operating expenses 3,978 2,929
Loss from operations (3,557) (2,880)
Other income (expenses):    
Interest expense (2) (8)
Interest income 38 2
Change in fair value of derivative liabilities 4,006 41
Offering costs of derivative liabilities (786)
Other income (net) 8
Total other income, net 3,264 35
Net loss before income taxes (293) (2,845)
Provision for income taxes
Net loss $ (293) $ (2,845)
Net loss per share – basic and diluted    
Basic – net loss $ (0.13) $ (11.51)
Diluted – net loss $ (1.74) $ (11.51)
Weighted average common shares outstanding:    
Basic 2,272,992 247,122
Diluted 2,558,059 247,122
Product [Member]    
Total revenue $ 240 $ 101
Grant And Contract [Member]    
Total revenue $ 299 $ 28